Citation Impact
Citing Papers
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Parkinson disease
2017 Standout
Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease
2010
Targeting Aβ and tau in Alzheimer's disease, an early interim report
2009
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Therapeutic modulation of Notch signalling — are we there yet?
2014
Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease
2014
Treatment Strategies Targeting Amyloid -Protein
2012
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Vascular dementia
2015 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Riluzole in the Treatment of Mood and Anxiety Disorders
2008
The glymphatic pathway in neurological disorders
2018 Standout
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
2013
Alzheimer's disease
2011 Standout
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
2011 Standout
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
2020
Ageing as a risk factor for neurodegenerative disease
2019 Standout
γ-Secretase Inhibition Reduces Spine DensityIn Vivovia an Amyloid Precursor Protein-Dependent Pathway
2009
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Cancer stem cells revisited
2017 Standout
γ-secretases: from cell biology to therapeutic strategies
2010
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Alzheimer’s Disease
2012
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
Blood protein predictors of brain amyloid for enrichment in clinical trials?
2015 StandoutNobel
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
2010
Novel pharmacological targets for the treatment of Parkinson's disease
2006
Alzheimer's disease
2016 Standout
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease<subtitle>A Randomized Controlled Trial</subtitle>
2009
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
2018
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
The neural basis of psychedelic action
2022 Standout
Normal aging modulates prefrontoparietal networks underlying multiple memory processes
2012
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Alzheimer's disease: strategies for disease modification
2010
Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606
2017
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal
2016
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
2015 StandoutNobel
The Pathobiology of Vascular Dementia
2013 Standout
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Non-dopaminergic treatments in development for Parkinson's disease
2008
The road to restoring neural circuits for the treatment of Alzheimer's disease
2016 Nature
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
The amyloid state and its association with protein misfolding diseases
2014 Standout
The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology
2010
Normal Cognitive Aging
2013 Standout
The Case for Diet: A Safe and Efficacious Strategy for Secondary Stroke Prevention
2015
γ-Secretase and its modulators: Twenty years and beyond
2019
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
2011
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Alzheimer's disease
2017 Standout
Validation of a Multiplex Assay for Simultaneous Quantification of Amyloid-β Peptide Species in Human Plasma with Utility for Measurements in Studies of Alzheimer's Disease Therapeutics
2012
Cerebrolysin for vascular dementia
2013
Neuroprotective lifestyles and the aging brain
2012
Conversion of metaplastic Barrett’s epithelium into post-mitotic goblet cells by γ-secretase inhibition
2010
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
2013 Standout
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
A brief overview of amyloids and Alzheimer's disease
2014
A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
2014
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Plasma tau in Alzheimer disease
2016 StandoutNobel
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
2015 StandoutNobel
Disease-modifying treatments for Alzheimer’s disease
2011
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
2012
Works of Abdullah Sherzai being referenced
Stroke, food groups, and dietary patterns: a systematic review
2012
Effects of serotonin 5‐HT1A agonist in advanced Parkinson's disease
2005
Glutamate release inhibition ineffective in Levodopa‐induced motor complications
2006
Nutrition and vascular dementia
2012
Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
2008
A Review of Functional Brain Imaging Correlates of Successful Cognitive Aging
2011
Influence of apolipoprotein E ɛ4 on rates of cognitive and functional decline in mild cognitive impairment
2010